Yahoo Italia Ricerca nel Web

Risultati di ricerca

  1. Vivek Ganapathy Ramaswamy è un imprenditore e giornalista statunitense candidato per le elezioni primarie del Partito Repubblicano del 2024. Classificato nel 2016 dalla rivista Forbes come il 24° imprenditore più ricco sotto i 40 anni con un patrimonio stimato di 600 milioni di dollari, Ramaswamy è un imprenditore i cui ...

  2. Vivek Ganapathy Ramaswamy (/ v ɪ ˈ v eɪ k r ɑː m ə ˈ s w ɑː m iː /; vih-VAYK rah-mə-SWAH-mee; born August 9, 1985) is an American entrepreneur and politician. He founded Roivant Sciences , a pharmaceutical company, in 2014.

    • Co-founder of Strive Asset Management
  3. 23 ago 2023 · How did Vivek Ramaswamy, a former biotech entrepreneur and political outsider, become a GOP presidential contender in 2024? This article follows his media blitz, his controversial views and his campaign strategy.

    • Vivek Ramaswamy1
    • Vivek Ramaswamy2
    • Vivek Ramaswamy3
    • Vivek Ramaswamy4
    • Vivek Ramaswamy5
  4. 3 giorni fa · Vivek Ramaswamy (born August 9, 1985, Cincinnati, Ohio) is a biotech entrepreneur who drew national attention with his bid for the Republican nomination in the 2024 U.S. presidential election. He first gained attention for his outspoken opposition to environment, social, and governance (ESG) investing, but his frequent media ...

  5. 28 set 2023 · Vivek Ramaswamy: Eight things Republican presidential candidate believes. 28 September 2023. By Gareth Evans,BBC News. Ramaswamy: 'I was clearly the winner of this thing' Vivek Ramaswamy,...

    • Vivek Ramaswamy1
    • Vivek Ramaswamy2
    • Vivek Ramaswamy3
    • Vivek Ramaswamy4
  6. 25 ago 2023 · US author and entrepreneur is confidently pushing unorthodox, right-wing ideas while promoting unity in his 2024 campaign. Vivek Ramaswamy delivered a Donald Trump-like performance at the first...

  7. 17 ago 2023 · Ramaswamy oversaw the development of several treatments that earned Food and Drug Administration approval, including a prostate cancer drug and one for overactive bladder. In 2016, he made Forbes...